Sabra Health Care REIT Inc/ US78573L1061 /
2024-06-07 10:00:00 PM | Chg. -0.2800 | Volume | Bid1:42:35 AM | Ask1:42:35 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
13.9900USD | -1.96% | 1.9 mill. Turnover: 22.2 mill. |
13.7500Bid Size: 400 | 14.4000Ask Size: 200 | 3.24 bill.USD | 8.58% | 233.17 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | - | - | - | - | - | ||||||
Intangible Assets | 101.5090 | 82.7960 | 54.0630 | 40.1310 | 30.8970 | ||||||
Long-Term Investments | 319.4600 | 288.7610 | 96.6800 | 134.9620 | 136.8430 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 257.8170 | 263.4850 | 537.1940 | 559.3040 | 554.4300 | ||||||
Cash and Cash Equivalents | 39.0970 | 59.0760 | 111.9960 | 49.3080 | 41.2850 | ||||||
Current Assets | - | - | - | - | - | ||||||
Total Assets | 6,069.2990 | 5,985.6030 | 5,966.7070 | 5,747.6720 | 5,386.1500 |
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 108.7920 | 146.2760 | 142.9890 | 142.2590 | 136.9810 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 2,580.8390 | 2,576.3750 | 2,587.1770 | 2,691.2770 | 2,583.6160 | ||||||
Share Capital | 2.0520 | 2.1060 | 2.3040 | 2.3100 | 2.3130 | ||||||
Total Equity | 3,488.4600 | 3,409.2280 | 3,379.5300 | 3,056.3950 | 2,802.5340 | ||||||
Minority Interests | 0.0000 | 0.0000 | - | - | - | ||||||
Total liabilities equity | 6,069.2990 | 5,985.6030 | 5,966.7070 | 5,747.6720 | 5,386.1500 |
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 661.7360 | 598.5690 | 569.5450 | 624.8110 | 647.5140 | ||||||
Depreciation (total) | 181.5490 | 176.7370 | 178.9910 | 187.7820 | 183.0870 | ||||||
Operating Result | - | - | - | - | - | ||||||
Interest Income | -126.6100 | -100.4000 | -98.6000 | -105.5000 | -113 | ||||||
Income Before Taxes | 79.2160 | 155.7260 | 80.6700 | 21.6690 | 18.6550 | ||||||
Income Taxes | 3.4020 | .7100 | 1.8450 | 1.2420 | 2.0020 | ||||||
Minority Interests Profit | -.0220 | 0.0000 | - | - | - | ||||||
Net Income | 68.9960 | 138.4170 | -113.2560 | -77.6050 | 13.7560 |
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 372.4750 | 354.8520 | 356.3900 | 315.7330 | 300.5710 | ||||||
Cash Flow from Investing Activities | 262.8440 | -136.4510 | -336.1960 | -216.2480 | 103.1300 | ||||||
Cash Flow from Financing | -646.1800 | -202.1090 | 30.1400 | -161.7070 | -410.3000 | ||||||
Decrease / Increase in Cash | -10.8610 | 16.2920 | 50.3340 | -62.2220 | -6.5990 | ||||||
Employees | 34 | - | - | - | - |